Analyst Ratings for Corcept Therapeutics (CORT) [Buys]
CORT Rating Summary
CORT Price Target Summary
- Highest: $42.00 (Truist Securities)
- Lowest: $25.00 (Leerink Partners)
- Average: $35.60
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$35.60 (+46.4%)
* Over Last 12-Mos
Rating Score: 4.1 / 10 Percentile Rank: 41%
Rating Score: 4.1 / 10 Percentile Rank: 41%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/4/2023 | Piper Sandler » Updated 10/18/2023 |
David Amsellem | New Coverage | Overweight (N/A) |
35.00 (31.00) |
21.66 (24.31) |
12.23% | Details |
6/27/2022 | Canaccord Genuity » Updated 12/13/2023 |
Edward Nash | New Coverage | Buy (N/A) |
38.00 (37.00) |
23.80 (24.31) |
2.14% | Details |